CYTOKINETICS, INCORPORATED Prepaid Expense and Other Assets, Current
CYTOKINETICS, INCORPORATED (CYTK) had Prepaid Expense and Other Assets, Current of $17.99 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Notes
us-gaap:PrepaidExpenseAndOtherAssetsCurrent · last filed 2026-08-06
- 2026-06-30: Prepaid Expense and Other Assets, Current $17.99M.
- 2026-03-31: Prepaid Expense and Other Assets, Current $13.93M.
- 2025-12-31: Prepaid Expense and Other Assets, Current $16.99M.
- 2025-09-30: Prepaid Expense and Other Assets, Current $13.01M.
| Period end | Prepaid Expense and Other Assets, Current |
|---|---|
| 2026-06-30 | $17.99M 10-Q · filed 2026-08-06 |
| 2026-03-31 | $13.93M 10-Q · filed 2026-05-05 |
| 2025-12-31 | $16.99M 10-Q · filed 2026-08-06 |
| 2025-09-30 | $13.01M 10-Q · filed 2025-11-05 |
| 2025-06-30 | $20.00M 10-Q · filed 2025-08-07 |
| 2025-03-31 | $15.82M 10-Q · filed 2025-05-06 |
| 2024-12-31 | $15.28M 10-K · filed 2026-02-26 |
| 2024-09-30 | $6.67M 10-Q · filed 2024-11-07 |
| 2024-06-30 | $11.04M 10-Q · filed 2024-08-09 |
| 2024-03-31 | $18.91M 10-Q · filed 2024-05-10 |
| 2023-12-31 | $11.94M 10-K · filed 2025-02-27 |
| 2023-09-30 | $19.68M 10-Q · filed 2023-11-03 |
| 2023-06-30 | $19.87M 10-Q · filed 2023-08-03 |
| 2023-03-31 | $15.66M 10-Q · filed 2023-05-05 |
| 2022-12-31 | $12.46M 10-K · filed 2024-02-28 |
| 2022-09-30 | $14.32M 10-Q · filed 2022-11-04 |
| 2022-06-30 | $14.25M 10-Q · filed 2022-08-05 |
| 2022-03-31 | $8.50M 10-Q · filed 2022-05-06 |
| 2021-12-31 | $12.21M 10-K · filed 2023-03-01 |
| 2021-09-30 | $16.66M 10-Q · filed 2021-11-05 |
| 2021-06-30 | $11.23M 10-Q · filed 2021-08-06 |
| 2021-03-31 | $3.03M 10-Q · filed 2021-05-07 |
| 2020-12-31 | $5.74M 10-K · filed 2022-02-25 |
| 2020-09-30 | $3.18M 10-Q · filed 2020-11-06 |
| 2020-06-30 | $3.64M 10-Q · filed 2020-08-07 |
| 2020-03-31 | $2.53M 10-Q · filed 2020-05-08 |
| 2019-12-31 | $3.48M 10-K · filed 2021-02-26 |
| 2019-09-30 | $3.92M 10-Q · filed 2019-11-01 |
| 2019-06-30 | $2.52M 10-Q · filed 2019-08-09 |
| 2019-03-31 | $3.14M 10-Q · filed 2019-05-09 |
| 2018-12-31 | $2.16M 10-K · filed 2020-03-04 |
| 2018-09-30 | $1.93M 10-Q · filed 2018-11-09 |
| 2018-06-30 | $1.68M 10-Q · filed 2018-08-07 |
| 2018-03-31 | $2.30M 10-Q · filed 2018-05-10 |
| 2017-12-31 | $4.29M 10-K · filed 2019-03-07 |
| 2017-09-30 | $4.42M 10-Q · filed 2017-11-03 |
| 2017-06-30 | $4.95M 10-Q · filed 2017-08-04 |
| 2017-03-31 | $3.56M 10-Q · filed 2017-05-04 |
| 2016-12-31 | $2.36M 10-K · filed 2018-03-05 |
| 2016-09-30 | $2.58M 10-Q/A · filed 2016-12-15 |
| 2016-06-30 | $6.25M 10-Q · filed 2016-08-04 |
| 2016-03-31 | $2.70M 10-Q · filed 2016-05-05 |
| 2015-12-31 | $1.65M 10-K · filed 2017-03-06 |
| 2015-09-30 | $2.48M 10-Q · filed 2015-11-05 |
| 2015-06-30 | $2.71M 10-Q · filed 2015-08-05 |
| 2015-03-31 | $1.97M 10-Q · filed 2015-05-04 |
| 2014-12-31 | $1.26M 10-K · filed 2016-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 |